Micro 3 - Viral evasion of host immunity Flashcards Preview

Year 2 Collin > Micro 3 - Viral evasion of host immunity > Flashcards

Flashcards in Micro 3 - Viral evasion of host immunity Deck (23)
Loading flashcards...
1
Q

internal viral proteins can be targets of cellular immunity. They tend to vary …. than surface antigens

A

Less than

2
Q

Every cell in the body has

A

MHC Class 1.

Viral and cellular peptides chopped up (by proteasome) and presented here (via ER and TAP protein)- they bind to T cell receptors on T Lymphocytes

3
Q

Cellular immunity clears viruses, but is short lived. Certain persistent viruses must evade cellular immunity, e.g. herpes.

A

Yah

4
Q

Viruses have evolved ways to prevent antigen presentation by MHC (1). Give examples

A

(before reading, remember TAP proteins on ER membrane move viral peptides into ER)

  1. HSV (ICP47) - blocks access of processed peptide to TAP
  2. CMV (cytomegalovirus - US6) - stops ATP binding to TAP so no translocation occurs into the ER
  3. EBV (EBNA1) - cannot be processed by proteasome
5
Q

How can viruses modulate tapasin function and prevent MHC transport

A

e. g.
1. CMV US3 binds tapasin - prevents peptides being loaded onto MHC
2. Adenovirus E3-19K prevents recruitment of TAP to tapasin and also retains MHC in ER

6
Q

Name a virus that interferes with MHC presentation at the cell surface

A

KSHV (Kaposis Sarcoma)HV

Its kK3 protein induces polyubiquitinylation and internalisation of MHC —> from the internalised endoscope, MHC passed to lysosomes where it is degraded

7
Q

HPV encounters both innate and cellular immune response. What does it produce to evade

A

Innate immunity:

E6 - binds to TYK2 and IRF3

E7 - binds to IRF9 and STING

Cellular immunity:

E5 and E7

8
Q

How do viruses avoid being killed by NKs with a missing self?

A

Viruses encode MHC analogues(CMV gpUL40) or up regulate MHC.

NK cells kill cells without MHC presentation

9
Q

Antigenic variation is one way in which viruses have evolved. Give examples of serotypes that circulate in humans

A

HIV - develops into a quasispecies

Rhinovirus - 100s of serotypes

Poliovirus - 3 serotypes

Dengue - 4 serotypes

10
Q

What is the major influenza viral antigen

A

Haemaglutinnin

11
Q

How does HIV evade antibodies

A

HIV spike GP120 resists neutralisation because:

  1. Large space between spikes - prevents Antibody crosslinking
  2. Extensive glycosylation - masks antibody epitopes
  3. Functionally important parts of molecule are poorly accessible (CD4 binding site). Decoy amino acids available to BCR and antibodies
  4. Huge variation in redundant amino acids (decoys) - means most antibodies are highly clade specific
12
Q

What type of vaccine do we have against HIV?

A

Broadly-neutralising HIV antibody - works on constant region (bind GP120) that cross react with many HIV strains.

Problem with broadly neutralising is that, whilst it may control viral load, viruses can mutate - then survive and expand

13
Q

Which viruses cause the common cold

A

Human rhinoviruses

14
Q

Poliovirus has 3 serotypes so

A

The vaccine is trivalent

But different ratio of each serotype (so one isn’t dominant, etc)

One serotype has been eradicated from the world –> were in the endgame now

15
Q

If you get dengue (4 serotypes) a second time, what can happen

A

Dengue haemorrhagic fever - leakage of blood plasma from capillaries

Detected by increase in RBC and decrease in protein level in blood

Tendency to bruise and bleed severely. Treated with IV fluid replacement.

All due to antigenic variation of dengue virus

16
Q

Describe Antibody Dependent enhancement (ADE) of dengue

A
  1. Person infected with a serotype of dengue (e.g. serotype 1)
  2. Mild dengue response - antibodies to serotype 1 made
  3. New infection of dengue (serotype 2), previous antibodies can bind to new virus serotype, but NOT neutralise (as different serotype).
  4. Antibody (bound) recognised by monocyte and binds to monocyte via Fc portion –> virus (serotype 2) now has a new type of cell it can infect, and compromised immunity.
  5. Viral load increases, dengue haemorrhagic fever
17
Q

Give an example of virus-mediated immunosuppression

A

Measles.

It infects CD150+ cells (e.g. memory Lymphocytes) —> erases immunological memory —> immunocompromised, so morbidity and mortality from other diseases as weaker immune system

Measles only has 1 serotype, definitely vaccinate

18
Q

Ebola virus makes soluble sGPs. What do these do

A

These are antibody decoys –> they mop up antibody and prevent the antibody from neutralising the actual virus. sGP is also immunosuppressive (inhibits neutrophils)

19
Q

Which type of viruses are more likely to have error-prone polymerases that promote antigenic variation?

A

RNA > DNA

20
Q

How do viruses counteract activation of innate immune system?

A

They encode proteins that cleave or target host immune factors for degradation

21
Q

What virus encodes a protein, “vif”, that counteracts APOBEC (IFN stimulated gene)

A

HIV - vif prevents APOBEC from inducing hypermutation of viral genome

22
Q

In Hep C virus, which protease cleaves MAVS and prevents activation of IFN

A

NS3/4A

23
Q

Genetic polymorphisms in what result in non-responsiveness to IFN treatmetn

A

IL-28b

Decks in Year 2 Collin Class (114):